Literature DB >> 24337696

Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.

Dusan Roncevic1, Jose-Alberto Palma, Jose Martinez, Niamh Goulding, Lucy Norcliffe-Kaufmann, Horacio Kaufmann.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease with two motor phenotypes: parkinsonian (MSA-P) and cerebellar (MSA-C). To elucidate whether in addition to the motor abnormalities there are other significant differences between these phenotypes, we performed a retrospective review of 100 patients (61 males, 39 females) with a diagnosis of possible (12 %), or probable (88 %) MSA. Four patients eventually had post-mortem confirmation (i.e., definite MSA). Sixty percent were classified as having MSA-P and 40 % as MSA-C. MSA-C and MSA-P patients had similar male prevalence (60 %), age of onset (56 ± 9 years), and frequency of OH (69 %). Brain MRI abnormalities were more frequent in MSA-C patients (p < 0.001). Mean survival was 8 ± 3 years for MSA-C and 9 ± 4 years for MSA-P patients (p = 0.22). Disease onset before 55 years predicted longer survival in both phenotypes. Initial autonomic involvement did not influence survival. We conclude that patients with both motor phenotypes have mostly similar survivals and demographic distributions. The differences here identified could help counseling of patients with MSA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337696      PMCID: PMC4134009          DOI: 10.1007/s00702-013-1133-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  15 in total

1.  Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.

Authors:  Martin Köllensperger; Felix Geser; Jean-Pierre Ndayisaba; Sylvia Boesch; Klaus Seppi; Karen Ostergaard; Erik Dupont; A Cardozo; Eduardo Tolosa; Michael Abele; Thomas Klockgether; Farid Yekhlef; Francois Tison; Christine Daniels; Günther Deuschl; Miguel Coelho; Cristina Sampaio; Maria Bozi; Niall Quinn; Anette Schrag; Chris J Mathias; Clare Fowler; Christer F Nilsson; Håkan Widner; Nicole Schimke; Wolfgang Oertel; Francesca Del Sorbo; Alberto Albanese; Maria Teresa Pellecchia; Paolo Barone; Ruth Djaldetti; Carlo Colosimo; Giuseppe Meco; Antonio Gonzalez-Mandly; Jose Berciano; Tanya Gurevich; Nir Giladi; Monique Galitzky; Olivier Rascol; Christoph Kamm; Thomas Gasser; Uwe Siebert; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Multiple system atrophy with prolonged survival.

Authors:  Han-Joon Kim; Beom S Jeon
Journal:  Mov Disord       Date:  2012-12-05       Impact factor: 10.338

3.  Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch.

Authors:  Igor N Petrovic; Helen Ling; Yasmine Asi; Zeshan Ahmed; Prashanth L Kukkle; Lili-Naz Hazrati; Anthony E Lang; Tamas Revesz; Janice L Holton; Andrew J Lees
Journal:  Mov Disord       Date:  2012-07-17       Impact factor: 10.338

4.  Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time.

Authors:  Nathalie Damon-Perrière; Alexandra Foubert-Samier; Valérie Cochen De Cock; Angélique Gerdelat-Mas; Rachel Debs; Anne Pavy-Le Traon; Jean-Michel Senard; Olivier Rascol; François Tison; Wassilios G Meissner
Journal:  Parkinsonism Relat Disord       Date:  2012-01-09       Impact factor: 4.891

5.  Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.

Authors:  Valeria Iodice; Axel Lipp; J Eric Ahlskog; Paola Sandroni; Robert D Fealey; Joseph E Parisi; Joseph Y Matsumoto; Eduardo E Benarroch; Kurt Kimpinski; Wolfgang Singer; Tonette L Gehrking; Jade A Gehrking; David M Sletten; Ann M Schmeichel; James H Bower; Sid Gilman; Juan Figueroa; Phillip A Low
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-06       Impact factor: 10.154

6.  Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy.

Authors:  Mari Tada; Osamu Onodera; Masayoshi Tada; Tetsutaro Ozawa; Yue-Shan Piao; Akiyoshi Kakita; Hitoshi Takahashi; Masatoyo Nishizawa
Journal:  Arch Neurol       Date:  2007-02

7.  Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.

Authors:  Regina Katzenschlager; Andrew Hughes; Andrew Evans; Alice J Manson; Marion Hoffman; Lesley Swinn; Hilary Watt; Kailash Bhatia; Niall Quinn; Andrew J Lees
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

8.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

Review 9.  Modelling progressive autonomic failure in MSA: where are we now?

Authors:  Sylvia Stemberger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

10.  The natural history of multiple system atrophy: a prospective European cohort study.

Authors:  Gregor K Wenning; Felix Geser; Florian Krismer; Klaus Seppi; Susanne Duerr; Sylvia Boesch; Martin Köllensperger; Georg Goebel; Karl P Pfeiffer; Paolo Barone; Maria Teresa Pellecchia; Niall P Quinn; Vasiliki Koukouni; Clare J Fowler; Anette Schrag; Christopher J Mathias; Nir Giladi; Tanya Gurevich; Erik Dupont; Karen Ostergaard; Christer F Nilsson; Håkan Widner; Wolfgang Oertel; Karla Maria Eggert; Alberto Albanese; Francesca del Sorbo; Eduardo Tolosa; Adriana Cardozo; Günther Deuschl; Helge Hellriegel; Thomas Klockgether; Richard Dodel; Cristina Sampaio; Miguel Coelho; Ruth Djaldetti; Eldad Melamed; Thomas Gasser; Christoph Kamm; Giuseppe Meco; Carlo Colosimo; Olivier Rascol; Wassilios G Meissner; François Tison; Werner Poewe
Journal:  Lancet Neurol       Date:  2013-02-05       Impact factor: 44.182

View more
  32 in total

1.  Progressive retinal structure abnormalities in multiple system atrophy.

Authors:  Carlos E Mendoza-Santiesteban; Jose-Alberto Palma; Jose Martinez; Lucy Norcliffe-Kaufmann; Thomas R Hedges; Horacio Kaufmann
Journal:  Mov Disord       Date:  2015-09-11       Impact factor: 10.338

2.  Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

Review 3.  Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis.

Authors:  Jose-Alberto Palma; Clara Fernandez-Cordon; Elizabeth A Coon; Phillip A Low; Mitchell G Miglis; Safwan Jaradeh; Arijit K Bhaumik; Praveen Dayalu; Elena Urrestarazu; Jorge Iriarte; Italo Biaggioni; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2015-03-05       Impact factor: 4.435

4.  SPG7: The Great Imitator of MSA-C Within the ILOCAs.

Authors:  Paula Salgado; Anna Latorre; Claudia Del Gamba; Elisa Menozzi; Bettina Balint; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2018-12-06

Review 5.  Novel therapeutic approaches in multiple system atrophy.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2014-06-14       Impact factor: 4.435

6.  Natural history of pure autonomic failure: A United States prospective cohort.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma; Italo Biaggioni; Phillip A Low; Wolfgang Singer; David S Goldstein; Amanda C Peltier; Cyndia A Shibao; Christopher H Gibbons; Roy Freeman; David Robertson
Journal:  Ann Neurol       Date:  2017-02       Impact factor: 10.422

7.  Sex and gender influence symptom manifestation and survival in multiple system atrophy.

Authors:  Elizabeth A Coon; Renee M Nelson; David M Sletten; Mariana D Suarez; J Eric Ahlskog; Eduardo E Benarroch; Paola Sandroni; Jay N Mandrekar; Phillip A Low; Wolfgang Singer
Journal:  Auton Neurosci       Date:  2019-04-24       Impact factor: 3.145

Review 8.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

Review 9.  Diagnosis of multiple system atrophy.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2017-10-23       Impact factor: 3.145

Review 10.  The neurogenetics of atypical parkinsonian disorders.

Authors:  Brent L Fogel; Mary C Clark; Daniel H Geschwind
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.